GERMANY UP CLOSE: IVD Industry Says EU Regulatory Reform Must Be Proportionate And Relevant
This article was originally published in SRA
Germany's IVDs industry is the largest in Europe, with a local market valued at €2.2bn (reagents and equipment/systems) in 2014-15. It accounts for 20% of the wider European market, but the overwhelmingly SMEs-based industry is nervous about the changes that the proposed EU IVD Regulation will bring, clearly worried that an inappropriately heavy regulatory hand will damage the sector’s ability to innovate. Ashley Yeo reports.
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.